As HDIVC directly attenuates the rise of both syndecan-1 and cfDNA at 48-h, this may provide a partial pathway into the mechanism of mortality benefit with HDIVC in subjects with sepsis induced ARDS (Figure 1 and Figure 2). This evidence concerns the gene SDC1 and Sepsis.